| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8662314 | International Journal of Cardiology | 2018 | 6 Pages |
Abstract
Rivaroxaban was associated with favorable NCB compared with warfarin. The NCB was attributable to lower rates of ischemic events and fatal or critical organ bleeding.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Adam S. Barnett, Derek D. Cyr, Shaun G. Goodman, Bennett S. Levitan, Zhong Yuan, Graeme J. Hankey, Daniel E. Singer, Richard C. Becker, Günter Breithardt, Scott D. Berkowitz, Jonathan L. Halperin, Werner Hacke, Kenneth W. Mahaffey,